샘플 요청 목록

 카트 문의
시장보고서
상품코드
1779835

세계의 복합부위 통증 증후군 시장

Complex Regional Pain Syndrome
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 373 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 복합부위 통증 증후군 시장은 2030년까지 1억 1,980만 달러에 달할 전망

2024년에 1억 510만 달러로 추정되는 세계의 복합부위 통증 증후군 시장은 2030년에는 1억 1,980만 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 2.2%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 약제 기반 요법은 CAGR 2.5%를 기록하며, 분석 기간 종료시에는 6,510만 달러에 달할 것으로 예측됩니다. 척수 자극치료 분야의 성장률은 분석 기간 중 CAGR 2.1%로 추정됩니다.

미국 시장은 2,860만 달러로 추정, 중국은 CAGR 4.2%로 성장 예측

미국의 복합부위 통증 증후군 시장은 2024년에 2,860만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 2,260만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 4.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 0.9%와 1.9%로 예측됩니다. 유럽에서는 독일이 CAGR 1.3%로 성장할 것으로 예측됩니다.

세계의 복합부위 통증 증후군 시장 - 주요 동향과 촉진요인 정리

복합부위통증증후군이 임상에서 주목받는 이유는?

복합부위통증증후군(CRPS)은 만성적이고 쇠약해지는 통증 증상으로, 일반적으로 사지 부상, 수술, 기타 외상 후 발생합니다. 극심한 통증, 부종, 피부색과 체온의 변화, 운동 기능 장애를 특징으로 하는 CRPS는 아직 충분히 이해되지 않았지만 환자에게는 매우 고통스러운 질환입니다. CRPS의 병태생리가 복잡하므로 의학계는 CRPS의 진단, 치료, 환자 관리 전반에 대한 개선에 점점 더 많은 노력을 기울이고 있습니다. CRPS가 주목받게된 주요 이유 중 하나는 수술 후 또는 외상 후 신경병증성 통증의 유병률이 증가했기 때문입니다. 전 세계에서 정형외과수술, 골절, 사지 손상 건수가 증가하는 가운데, CRPS의 발생률은 증가 추세를 보이고 있습니다. 또한 이 질환은 초기에 오진되거나 간과되는 경우가 많아 만성 통증과 장기적인 신체적 장애로 이어지는 경우가 많습니다. 따라서 의료 전문가들은 질병의 진행을 막기 위해 다학제적 통증 관리 접근법을 포함한 조기 개입 전략을 강조하고 있습니다. 또한 전문 통증관리센터와 CRPS 전용 치료 프로그램의 출현도 환자 치료의 향상을 촉진하고 있습니다. 이들 센터에서는 약물 치료, 물리치료, 중재적 통증치료 등을 병행하여 환자의 예후를 개선하고 있습니다. 또한 환자 지원 단체와 인식 개선 캠페인이 CRPS의 병태를 조명하고, 진단율 향상과 효과적인 치료 옵션에 대한 수요로 이어지고 있습니다.

CRPS의 진단과 치료의 발전은 무엇인가?

CRPS의 진단은 결정적인 바이오마커나 표준화된 진단 테스트가 없기 때문에 여전히 어려운 과제입니다. 기존에는 임상 의사들이 CRPS를 확인하기 위해 임상 증상, 부다페스트 기준, 뼈 스캔이나 MRI와 같은 영상 진단 기술에 의존해 왔습니다. 하지만 기술의 발전으로 진단의 정확도가 높아져 조기 발견이 가능해졌습니다. 기능적 MRI(fMRI)나 열화상 촬영과 같은 새로운 영상 진단법은 CRPS와 관련된 신경 염증과 비정상적인 통증 처리 패턴을 식별할 수 있으므로 연구가 진행되고 있습니다. 약리학적 치료는 CRPS 관리의 핵심이며, 새로운 치료제에 대한 관심이 높아지고 있습니다. 기존 치료법으로는 비스테로이드성 항염증약(NSAIDs), 코르티코스테로이드, 신경병증성 통증 치료제(가바펜티노이드, 삼환계 항우울제 등)가 사용되어 왔습니다. 그러나 케타민 정맥주사 요법, 비스포스포네이트 제제, 면역조절제 등의 새로운 치료법이 CRPS와 관련된 통증과 염증을 감소시키는 효과가 있는 것으로 주목받고 있습니다. 척수 자극(SCS) 및 후근신경절(DRG) 자극과 같은 중재적 통증 관리 기술은 중증 난치성 통증을 가진 CRPS 환자들의 치료 환경에 혁명을 가져왔습니다. 이러한 신경조절 요법은 비정상적인 신경 신호 전달을 조절하여 표적화된 통증 완화를 제공함으로써 이동성과 삶의 질을 개선합니다. 또한 줄기세포 치료나 혈소판풍부혈장(PRP) 주사와 같은 재생의료 접근법도 손상된 신경조직을 복구하고 CRPS와 관련된 신경 염증을 감소시킬 수 있는 것으로 연구되고 있습니다.

시장 동향은 CRPS 치료의 미래를 어떻게 형성하고 있는가?

개별화된 통증 관리에 대한 관심이 높아지면서 CRPS 치료 프로토콜에 큰 변화를 가져오고 있습니다. CRPS의 증상과 병의 진행이 다양하므로 의료진은 치료에 대한 개인별 반응에 따라 치료 계획을 조정하는 환자 중심 접근법을 채택하고 있습니다. 이러한 변화는 최적의 통증 완화를 달성하기 위해 약리학적 치료, 중재적 치료, 재활 치료를 결합한 복합적 통증 관리 전략의 통합으로 이어지고 있습니다. CRPS 관리에서 디지털 헬스 솔루션의 역할도 확대되고 있습니다. 원격의료 플랫폼과 모바일 헬스 용도는 CRPS 환자의 원격 통증 상담, 자가 관리 프로그램, 가상 물리치료 세션을 가능하게 하고 있습니다. 이러한 디지털 개입은 거동이 불편한 환자들에게 특히 유용하며, 병원을 자주 방문하지 않고도 지속적인 치료를 받을 수 있습니다. 또한 웨어러블 통증 모니터링 장치의 통합은 임상의가 실시간으로 통증의 변화와 치료 효과를 평가하는 데 도움이 되고 있습니다. CRPS에 대한 규제의 진전과 연구 자금 증가가 시장 성장에 더욱 기여하고 있습니다. 정부와 의료 기관은 CRPS에 대한 연구 개선의 필요성을 인식하고 있으며, 이는 신약 후보와 혁신적인 치료 접근법을 모색하는 임상시험으로 이어지고 있습니다. 또한 CRPS가 장애 급여 프로그램 및 보험 적용 범위에 포함됨에 따라 환자의 치료 접근성이 향상되어 첨단 치료법에 대한 수요가 증가하고 있습니다.

시장을 자극하는 주요 성장 요인은 무엇인가?

복합부위통증증후군 시장의 성장은 신경조절치료의 발전, 인식 개선 및 조기 진단, 디지털 헬스 솔루션의 확대 등 여러 요인에 의해 촉진되고 있습니다. 주요 성장 요인 중 하나는 만성 통증을 앓고 있는 CRPS 환자에게 매우 효과적임이 입증되고 있는 중재적 통증 관리 기술, 특히 척수 자극과 후근신경절 자극의 채택이 증가하고 있다는 점입니다. 이러한 시술은 장기적인 통증 완화 효과가 있고, 오피오이드 약물에 대한 의존도를 낮출 수 있다는 점에서 많은 지지를 받고 있습니다. 제약사 및 의료기기 업체들의 연구개발 활성화도 또 다른 큰 성장 요인입니다. 신약, 생물제제, 신경조절 기술을 평가하는 임상시험이 진행 중이므로 CRPS 치료의 전망은 큰 진전을 이룰 것으로 예측됩니다. 줄기세포를 이용한 치료법을 포함한 재생의료에 대한 관심이 높아지면서 CRPS 환자의 신경 회복과 통증 완화에 대한 새로운 가능성을 열어주고 있습니다. 다학제적 통증 관리 센터의 확장은 시장 성장을 더욱 촉진하고 있습니다. 의료진은 전통적인 약물 치료와 더불어 물리치료, 심리적 지원, 생활습관 개입을 통합하여 CRPS 치료에 대한 총체적 접근을 강조하고 있습니다. 이러한 종합적인 접근법은 환자의 예후를 개선하고, 의료 기관에서 CRPS에 특화된 치료 프로토콜을 채택하는 사례가 증가하고 있습니다. 또한 디지털 헬스 개입의 부상으로 환자 참여와 치료 순응도가 향상되고 있습니다. 원격의료 플랫폼, 웨어러블 통증 모니터링 기기, AI를 활용한 통증 관리 툴은 개인화된 지식과 원격 치료 솔루션을 제공함으로써 CRPS 치료에 혁명을 일으키고 있습니다. 기술이 통증 관리의 전망을 계속 재구성하고 있는 가운데, CRPS의 고급 치료에 대한 수요는 향후 수년간 급증할 것으로 예측됩니다.

이러한 요인들이 종합적으로 복합부위통증증후군 시장의 미래를 형성하고 있으며, 기술 혁신, 진화하는 치료 패러다임, 전문적인 CRPS 치료에 대한 접근성 증가로 인해 업계는 크게 성장할 태세를 갖추고 있습니다.

부문

치료 유형(약물 요법, 척수 자극치료, 외과적 교감신경 절제 요법, 기타 치료 유형), 질환 유형(CRPS I 질환, CRPS II 질환, CRPS-NOS 질환), 유통 채널(병원 약국 유통 채널, 드러그스토어 유통 채널, 소매 약국 유통 채널, 온라인 약국 유통 채널)

조사 대상 기업의 예

  • Abbott Laboratories
  • Axovant Gene Therapies Ltd.
  • Biogen Inc.
  • Biopharmaceutical Research Company(BRC)
  • Boston Scientific Corporation
  • Collegium Pharmaceutical
  • Eli Lilly and Company
  • Grunenthal Group
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Medtronic
  • NeurogesX
  • Nevro Corp.
  • Pfizer Inc.
  • PharmaTher Holdings Ltd.
  • Purdue Pharma
  • Sandoz
  • Soin Therapeutics
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.06

Global Complex Regional Pain Syndrome Market to Reach US$119.8 Million by 2030

The global market for Complex Regional Pain Syndrome estimated at US$105.1 Million in the year 2024, is expected to reach US$119.8 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Drugs-based Therapy, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$65.1 Million by the end of the analysis period. Growth in the Spinal Cord Stimulation Therapy segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.6 Million While China is Forecast to Grow at 4.2% CAGR

The Complex Regional Pain Syndrome market in the U.S. is estimated at US$28.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$22.6 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global Complex Regional Pain Syndrome Market - Key Trends & Drivers Summarized

Why Is Complex Regional Pain Syndrome Gaining Increased Clinical Attention?

Complex Regional Pain Syndrome (CRPS) is a chronic and debilitating pain condition that typically develops after an injury, surgery, or other trauma to the limbs. Characterized by severe pain, swelling, changes in skin color and temperature, and motor dysfunction, CRPS remains a poorly understood yet highly distressing condition for patients. Given the complexity of its pathophysiology, the medical community has been increasingly focused on improving its diagnosis, treatment, and overall patient management. One of the primary reasons for the growing attention toward CRPS is the increasing prevalence of post-surgical and post-traumatic neuropathic pain. With a rising number of orthopedic surgeries, fractures, and limb injuries worldwide, the incidence of CRPS has shown an upward trend. Moreover, the condition is often misdiagnosed or overlooked in its early stages, leading to chronic pain and long-term disability. Consequently, healthcare professionals are emphasizing early intervention strategies, including multidisciplinary pain management approaches, to prevent disease progression. The emergence of specialized pain management centers and dedicated CRPS treatment programs is also facilitating better patient care. These centers employ a combination of pharmacological therapies, physical therapy, and interventional pain procedures to improve patient outcomes. Additionally, patient advocacy groups and awareness campaigns are shedding light on the condition, leading to increased diagnosis rates and demand for effective therapeutic options.

What Are the Advancements in CRPS Diagnosis and Treatment?

The diagnosis of CRPS remains a challenge due to the lack of definitive biomarkers and standardized diagnostic tests. Traditionally, clinicians rely on clinical symptoms, the Budapest criteria, and diagnostic imaging techniques such as bone scans and MRI to confirm CRPS. However, technological advancements are improving diagnostic accuracy and enabling earlier detection. Emerging imaging modalities, such as functional MRI (fMRI) and thermography, are being explored for their potential in identifying CRPS-related neuroinflammation and abnormal pain processing patterns. Pharmacological treatment remains a cornerstone of CRPS management, with a growing focus on novel therapeutic agents. Traditional treatment approaches involve the use of nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and neuropathic pain medications such as gabapentinoids and tricyclic antidepressants. However, newer therapies, including intravenous ketamine infusions, bisphosphonates, and immune-modulating drugs, are gaining attention for their efficacy in reducing CRPS-associated pain and inflammation. Interventional pain management techniques, such as spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation, have revolutionized the treatment landscape for CRPS patients with severe and refractory pain. These neuromodulation therapies provide targeted pain relief by modulating abnormal nerve signaling, thereby improving mobility and quality of life. Additionally, regenerative medicine approaches, including stem cell therapy and platelet-rich plasma (PRP) injections, are being investigated for their potential in repairing damaged nerve tissues and reducing neuroinflammation associated with CRPS.

How Are Market Trends Shaping the Future of CRPS Treatment?

The increasing focus on personalized pain management is driving significant changes in CRPS treatment protocols. Given the heterogeneity of CRPS symptoms and disease progression, healthcare providers are adopting a patient-centric approach that tailors treatment plans based on individual responses to therapy. This shift is leading to the integration of multimodal pain management strategies, combining pharmacological, interventional, and rehabilitative therapies to achieve optimal pain relief. The role of digital health solutions in CRPS management is also expanding. Telemedicine platforms and mobile health applications are enabling remote pain consultations, self-management programs, and virtual physical therapy sessions for CRPS patients. These digital interventions are particularly beneficial for individuals with mobility limitations, ensuring continuous access to care without frequent hospital visits. Moreover, the integration of wearable pain monitoring devices is helping clinicians assess pain fluctuations and treatment efficacy in real time. Regulatory advancements and increased research funding for CRPS are further contributing to market growth. Governments and healthcare organizations are recognizing the need for improved CRPS research, leading to clinical trials exploring novel drug candidates and innovative treatment approaches. Additionally, the inclusion of CRPS in disability benefit programs and insurance coverage is improving treatment accessibility for patients, thereby driving demand for advanced therapies.

What Are the Key Growth Drivers Fueling the Market?

The growth in the Complex Regional Pain Syndrome market is driven by several factors, including advancements in neuromodulation therapies, increasing awareness and early diagnosis, and the expansion of digital health solutions. One of the primary growth drivers is the rising adoption of interventional pain management techniques, particularly spinal cord stimulation and dorsal root ganglion stimulation, which are proving to be highly effective for CRPS patients with chronic pain. These procedures are gaining traction due to their long-term pain relief benefits and reduced dependence on opioid medications. The increasing research and development efforts by pharmaceutical companies and medical device manufacturers are another major growth factor. With ongoing clinical trials evaluating new drug formulations, biologics, and neuromodulation technologies, the CRPS treatment landscape is expected to witness significant advancements. The growing interest in regenerative medicine, including stem cell-based therapies, is also opening new possibilities for nerve repair and pain relief in CRPS patients. The expansion of multidisciplinary pain management centers is further driving market growth. Healthcare providers are emphasizing a holistic approach to CRPS treatment by integrating physical therapy, psychological support, and lifestyle interventions alongside conventional pharmacotherapy. This comprehensive approach is improving patient outcomes and increasing the adoption of CRPS-specific treatment protocols across healthcare institutions. Additionally, the rise of digital health interventions is enhancing patient engagement and treatment adherence. Telehealth platforms, wearable pain monitoring devices, and AI-powered pain management tools are revolutionizing CRPS care by offering personalized insights and remote therapeutic solutions. As technology continues to reshape the pain management landscape, the demand for advanced CRPS treatments is expected to surge in the coming years.

With these factors collectively shaping the future of the Complex Regional Pain Syndrome market, the industry is poised for significant growth, driven by technological innovations, evolving treatment paradigms, and increasing accessibility to specialized CRPS therapies.

SCOPE OF STUDY:

The report analyzes the Complex Regional Pain Syndrome market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Therapy Type (Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy, Other Therapy Types); Disease Type (CRPS I Disease, CRPS II Disease, CRPS-NOS Disease); Distribution Channel (Hospital Pharmacies Distribution Channel, Drug Stores Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Axovant Gene Therapies Ltd.
  • Biogen Inc.
  • Biopharmaceutical Research Company (BRC)
  • Boston Scientific Corporation
  • Collegium Pharmaceutical
  • Eli Lilly and Company
  • Grunenthal Group
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Medtronic
  • NeurogesX
  • Nevro Corp.
  • Pfizer Inc.
  • PharmaTher Holdings Ltd.
  • Purdue Pharma
  • Sandoz
  • Soin Therapeutics
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Complex Regional Pain Syndrome - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Clinical Awareness and Diagnosis Rates Drive Demand for Targeted CRPS Therapies
    • OEM Innovations in Nerve Blocks and Neuromodulation Expand Interventional Treatment Options
    • Growing Use of Multimodal Pain Management Strategies Supports Adoption of Combination Therapies
    • Expansion of Physical Rehabilitation and Occupational Therapy Programs Enhances Non-Pharmacologic Management
    • Rising Investment in CRPS Research and Clinical Trials Accelerates Drug Pipeline Activity
    • OEM Development of Intrathecal Drug Delivery Systems Enhances Localized Pain Control
    • Integration of Telehealth and Remote Pain Assessment Tools Expands Access to Specialized Care
    • Growing Emphasis on Early Diagnosis and Functional Recovery Supports Holistic Treatment Approaches
    • OEM Focus on Cannabinoid and NMDA Antagonist Therapies Drives Novel Drug Development
    • Surging Patient Advocacy and Education Campaigns Improve Treatment-Seeking Behavior
    • Expansion of Biologics and Regenerative Therapies for Nerve Repair Fuels Market Innovation
    • OEM Collaboration With Pain Management Clinics Accelerates Adoption of Interventional Techniques
    • Increasing Insurance Coverage and Reimbursement for CRPS Therapies Enhances Access
    • Use of Wearable Pain Monitoring Devices Enables Personalized and Continuous Care Plans
    • Rising Interest in Non-Invasive Neuromodulation Solutions Encourages Home-Based Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Complex Regional Pain Syndrome Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Complex Regional Pain Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drugs-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drugs-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Drugs-based Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spinal Cord Stimulation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spinal Cord Stimulation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Surgical Sympathectomy Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Surgical Sympathectomy Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Surgical Sympathectomy Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Therapy Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Therapy Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Therapy Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Drug Stores Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for CRPS I Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for CRPS I Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for CRPS I Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for CRPS II Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for CRPS II Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for CRPS II Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for CRPS-NOS Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for CRPS-NOS Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for CRPS-NOS Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • JAPAN
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • CHINA
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • EUROPE
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Complex Regional Pain Syndrome by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • FRANCE
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • GERMANY
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • INDIA
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Complex Regional Pain Syndrome by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Complex Regional Pain Syndrome by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
  • AFRICA
    • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제